BioCorRx Inc. BICX
$0.25
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -58.97% | 241.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -58.97% | 241.96% | |||
| Cost of Revenue | 475.40% | 107.48% | |||
| Gross Profit | -130.10% | 1.88% | |||
| SG&A Expenses | -11.50% | 43.77% | |||
| Depreciation & Amortization | -12.50% | 108.97% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.44% | 203.89% | |||
| Operating Income | -54.33% | -77.76% | |||
| Income Before Tax | -16.49% | -82.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.49% | -82.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 28.57% | -97.20% | |||
| Net Income | -16.07% | -250.42% | |||
| EBIT | -54.33% | -77.76% | |||
| EBITDA | -55.13% | -79.36% | |||
| EPS Basic | -1.54% | -236.55% | |||
| Normalized Basic EPS | -10.98% | -155.10% | |||
| EPS Diluted | -1.54% | -236.55% | |||
| Normalized Diluted EPS | -10.98% | -155.10% | |||
| Average Basic Shares Outstanding | 14.14% | 10.16% | |||
| Average Diluted Shares Outstanding | 14.14% | 10.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||